Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Next Generation Cancer Diagnostic Devices market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Next Generation Cancer Diagnostic Devicesmarket, defines the market attractiveness level of Next Generation Cancer Diagnostic Devices market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Next Generation Cancer Diagnostic Devices industry, describes the types of Next Generation Cancer Diagnostic Devices market, the applications of major players and the market size, and deeply analyzes the current situation of the global Next Generation Cancer Diagnostic Devices market and the development prospects and opportunities of Next Generation Cancer Diagnostic Devices industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Next Generation Cancer Diagnostic Devices market in Chapter 13.
By Player:
Abbott Laboratories(US)
Siemens Healthcare(Germany)
Agilent Technologies Inc(Germany)
GE Healthcare(England)
Johnson & Johnson(US)
By Type:
Next Generation Sequencing
qPCR & Multiplexing
Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
Protein Microarrays
DNA Microarrays
By End-User:
Biomarker Development
CTC Analysis
Proteomic Analysis
Epigenetic Analysis
Genetic Analysis
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Next Generation Cancer Diagnostic Devices Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Next Generation Cancer Diagnostic Devices Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Next Generation Cancer Diagnostic Devices Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Next Generation Cancer Diagnostic Devices Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Next Generation Cancer Diagnostic Devices Market Analysis and Outlook to 2022
-
7.1 Global Next Generation Cancer Diagnostic Devices Consumption (2017-2022)
-
7.2 United States Next Generation Cancer Diagnostic Devices Consumption (2017-2022)
-
7.3 Europe Next Generation Cancer Diagnostic Devices Consumption (2017-2022)
-
7.4 China Next Generation Cancer Diagnostic Devices Consumption (2017-2022)
-
7.5 Japan Next Generation Cancer Diagnostic Devices Consumption (2017-2022)
-
7.6 India Next Generation Cancer Diagnostic Devices Consumption (2017-2022)
-
7.7 South Korea Next Generation Cancer Diagnostic Devices Consumption (2017-2022)
8 Region and Country-wise Next Generation Cancer Diagnostic Devices Market Analysis and Outlook to 2028
-
8.1 Global Next Generation Cancer Diagnostic Devices Consumption Forecast (2022-2028)
-
8.2 United States Next Generation Cancer Diagnostic Devices Consumption Forecast (2022-2028)
-
8.3 Europe Next Generation Cancer Diagnostic Devices Consumption Forecast (2022-2028)
-
8.4 China Next Generation Cancer Diagnostic Devices Consumption Forecast (2022-2028)
-
8.5 Japan Next Generation Cancer Diagnostic Devices Consumption Forecast (2022-2028)
-
8.6 India Next Generation Cancer Diagnostic Devices Consumption Forecast (2022-2028)
-
8.7 South Korea Next Generation Cancer Diagnostic Devices Consumption Forecast (2022-2028)
9 Global Next Generation Cancer Diagnostic Devices Market Outlook by Types and Applications to 2022
-
9.1 Global Next Generation Cancer Diagnostic Devices Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Next Generation Sequencing Consumption and Growth Rate (2017-2022)
-
9.1.2 Global qPCR & Multiplexing Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR) Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Protein Microarrays Consumption and Growth Rate (2017-2022)
-
9.1.5 Global DNA Microarrays Consumption and Growth Rate (2017-2022)
-
9.2 Global Next Generation Cancer Diagnostic Devices Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Biomarker Development Consumption and Growth Rate (2017-2022)
-
9.2.2 Global CTC Analysis Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Proteomic Analysis Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Epigenetic Analysis Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Genetic Analysis Consumption and Growth Rate (2017-2022)
10 Global Next Generation Cancer Diagnostic Devices Market Outlook by Types and Applications to 2028
-
10.1 Global Next Generation Cancer Diagnostic Devices Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Next Generation Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global qPCR & Multiplexing Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Protein Microarrays Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global DNA Microarrays Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Next Generation Cancer Diagnostic Devices Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Biomarker Development Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global CTC Analysis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Proteomic Analysis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Epigenetic Analysis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Genetic Analysis Consumption Forecast and Growth Rate (2022-2028)
11 Global Next Generation Cancer Diagnostic Devices Import and Export Analysis (Top 5 Countries)
-
11.1 Global Next Generation Cancer Diagnostic Devices Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Next Generation Cancer Diagnostic Devices Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Next Generation Cancer Diagnostic Devices Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Next Generation Cancer Diagnostic Devices Market Competitive Analysis
-
14.1 Abbott Laboratories(US)
-
14.1.1 Abbott Laboratories(US) Company Details
-
14.1.2 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Product and Service
-
14.2 Siemens Healthcare(Germany)
-
14.2.1 Siemens Healthcare(Germany) Company Details
-
14.2.2 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Product and Service
-
14.3 Agilent Technologies Inc(Germany)
-
14.3.1 Agilent Technologies Inc(Germany) Company Details
-
14.3.2 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Product and Service
-
14.4 GE Healthcare(England)
-
14.4.1 GE Healthcare(England) Company Details
-
14.4.2 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Product and Service
-
14.5 Johnson & Johnson(US)
-
14.5.1 Johnson & Johnson(US) Company Details
-
14.5.2 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Next Generation Cancer Diagnostic Devices
-
Figure Next Generation Cancer Diagnostic Devices Picture
-
Table Global Next Generation Cancer Diagnostic Devices Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Next Generation Cancer Diagnostic Devices Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Next Generation Cancer Diagnostic Devices Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Next Generation Cancer Diagnostic Devices Consumption by Country (2017-2022)
-
Figure United States Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2017-2022)
-
Table Europe Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2017-2022)
-
Figure China Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2017-2022)
-
Figure Japan Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2017-2022)
-
Figure India Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2017-2022)
-
Figure South Korea Next Generation Cancer Diagnostic Devices Consumption and Growth Rate (2017-2022)
-
Figure Global Next Generation Cancer Diagnostic Devices Consumption Forecast by Country (2022-2028)
-
Figure United States Next Generation Cancer Diagnostic Devices Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Next Generation Cancer Diagnostic Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Next Generation Cancer Diagnostic Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Next Generation Cancer Diagnostic Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Next Generation Cancer Diagnostic Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Next Generation Cancer Diagnostic Devices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Next Generation Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Global qPCR & Multiplexing Consumption and Growth Rate (2017-2022)
-
Figure Global Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR) Consumption and Growth Rate (2017-2022)
-
Figure Global Protein Microarrays Consumption and Growth Rate (2017-2022)
-
Figure Global DNA Microarrays Consumption and Growth Rate (2017-2022)
-
Figure Global Biomarker Development Consumption and Growth Rate (2017-2022)
-
Figure Global CTC Analysis Consumption and Growth Rate (2017-2022)
-
Figure Global Proteomic Analysis Consumption and Growth Rate (2017-2022)
-
Figure Global Epigenetic Analysis Consumption and Growth Rate (2017-2022)
-
Figure Global Genetic Analysis Consumption and Growth Rate (2017-2022)
-
Figure Global Next Generation Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global qPCR & Multiplexing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Protein Microarrays Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global DNA Microarrays Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biomarker Development Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CTC Analysis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Proteomic Analysis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Epigenetic Analysis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Genetic Analysis Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Next Generation Cancer Diagnostic Devices Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Next Generation Cancer Diagnostic Devices Export by Region (Top 5 Countries) (2017-2028)
-
Table Abbott Laboratories(US) (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Product and Service
-
Table Siemens Healthcare(Germany) (Foundation Year, Company Profile and etc.)
-
Table Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Product and Service
-
Table Agilent Technologies Inc(Germany) (Foundation Year, Company Profile and etc.)
-
Table Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Product and Service
-
Table GE Healthcare(England) (Foundation Year, Company Profile and etc.)
-
Table GE Healthcare(England) Next Generation Cancer Diagnostic Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table GE Healthcare(England) Next Generation Cancer Diagnostic Devices Product and Service
-
Table Johnson & Johnson(US) (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Product and Service
-
